Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
We have an experienced team that has advanced multiple product candidates in parallel that focus on a range of debilitating diseases with significant unmet medical need. We continue to explore expanding our pipeline in order to develop life-changing medicines for patients who need it most.
We are focused on hiring and retaining a highly skilled team that has extensive experience and specific skill sets relating to the selection, development, and commercialization of transformative therapies. Whether in development, research, manufacturing, technical operations, or general / administrative functions, we depend on a brilliant team to support our mission of building a global, generational company.
Our benefits are competitive, and we offer dynamic career opportunities across our organization fostering a culture that embraces passion and rapid execution.
|
|
|
201-500 employees
View all Kiniksa Pharmaceuticals employees
|
|
Biotechnology
|
|
100 Hayden Ave, Lexington, Massachusetts 02421, US
|
|
2015
|
Jennifer Hedly-mason is the CEO of Kiniksa Pharmaceuticals.
The decision makers in Kiniksa Pharmaceuticals are Bernie Kalmbach, Dan Girard, John Mckenna, etc. Click to Find Kiniksa Pharmaceuticals decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.